Breztri Aerosphere (budesonide/formoterol fumarate/glycopyrronium) - AstraZeneca
Breztri Aerosphere: Data from P3 ATHLOS trial (NCT06067828) for COPD in H2 2025 (AstraZeneca) - Feb 6, 2025 - Q4 & FY2024 Results: Data from P3 THARROS trial (NCT06283966) for COPD post 2026 
P3 data Chronic Obstructive Pulmonary Disease
https://www.astrazeneca.com/content/dam/az/PDF/2024/fy/Full-year-and-Q4-2024-results-clinical-trials-appendix.pdf
 
Feb 6, 2025
 
 
0807fbea-1885-4377-8b5f-eab123785b4e.png